MASCT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MASCT, covering 2016-08-11 to 2016-08-11. Get the full timeline:
Most recent: Clinical Trial Update: Study of Apatinib and MASCT in Patients With Advanced Solid Tumors [Phase 1, Phase 2]